RG
EBS icon

Renaissance Group’s Emergent Biosolutions EBS Stock Holding History

Renaissance Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,129
Closed -$941K – 283
2021
Q1 		$941K Buy
10,129
+320
+3% +$32.8K 0.04% 174
2020
Q4 		$879K Buy
9,809
+21
+0.2% +$1.93K 0.04% 168
2020
Q3 		$1.01M Sell
9,788
-128
-1% -$13.8K 0.05% 120
2020
Q2 		$784K Buy
+9,916
New +$739K 0.04% 142
2014
Q3 		– Sell
-10,212
Closed -$229K – 268
2014
Q2 		$229K Sell
10,212
-167
-2% -$3.89K 0.01% 260
2014
Q1 		$262K Buy
+10,379
New +$262K 0.01% 184

Other funds holding EBS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return